Exogenous surfactant preserves lung function and reduces alveolar evans blue dye influx in a rat model of ventilation-induced lung injury

Anesthesiology

Volumn 89, Issue 2, 1998, Pages 467-474

  Verbrugge, Serge J C ^b   Vazguez De Anda, Gilberto ^b   Gommers, Diederik ^b   Neggers, Sebastian J C M M ^b   Sorm, Vera ^b   Böhm, Stephan H ^b   Lachmann, Burkhard ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

Lung mechanics; Mechanical ventilation; PEEP; Pulmonary surfactants

Indexed keywords

ENFLURANE; EVANS BLUE; LIDOCAINE; NITROUS OXIDE; PANCURONIUM BROMIDE; PENTOBARBITAL; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DOSE RESPONSE; INSPIRATORY RESERVE VOLUME; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INFLATION; LUNG INJURY; LUNG MECHANICS; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; TOTAL LUNG CAPACITY;

ANIMALS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; EVANS BLUE; LUNG; MALE; ORGAN SIZE; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS;

EID: 0344351822     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199808000-00024     Document Type: Article

References (31)

1. Webb HH, Tierney DF: Experimental pulmonary edema due to high intermittent positive pressure ventilation with high inflation pressures: Protection by positive end-expiratory pressure. Am Rev Respir Dis 1974; 110:556-65
2. Dreyfuss D, Basset G, Soler P, Saumon G: Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985; 132:880-4
3. Dreyfuss D, Soler P, Basset G, Saumon G: High inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159-64
4. Dreyfuss D, Saumon G: Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis 1993; 148:1194-203
5. Gommers D, Lachmann B: Surfactant therapy in the adult patient. Curr Opin Grit Care 1995; 1:57-61
6. Verbrugge SJC, Böhm SH, Gommers D, Zimmerman LJI, Lachmann B: Surfactant impairment after mechanical ventilation with large alveolar surface area changes and the effects of positive end-expiratory pressure. Br J Anaesth 1998; 80:360-4
7. Gross NJ, Narine KR: Surfactant subtypes in mice: Metabolic relationship and conversion in vitro. J Appl Physiol 1989; 66:414-21
8. Veldhuizen RAW, Marcou J, Yao LJ, McCraig L, Ito Y, Lewis JF: Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol 1996; 270:L152-8
9. Gommers D, Vilstrup C, Bos JAH, Larsson A, Werner O, Hannappel E, Lachmann B: Exogenous surfactant therapy increases static lung compliance and, cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993; 21:567-74
10. Nilsson R, Grossmann G, Robertson B: Bronchiolar epithelial lesions induced in the premature rabbit neonate by short periods of artificial ventilation. Acta Path Microbiol Scand 1980; 88:359-67
11. Gruenwald P: A numerical index of the stability of lung expansion. J Appl Physiol 1963; 18:665-7
12. van Daal GJ, Bos JAH, Eijking EP, Gommers D, Hannapel E, Lachmann B: Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis 1992; 145:859-63
13. Veldhuizen RAW, Inchley K, Hearn SA, Lewis JF, Possmayer F: Degradation of surfactant associated protein B (SP-B) during in vitro conversion of large into small surfactant aggregates. Biochem J 1993; 295:141-7
14. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7
15. Rouser G, Fleischer S, Yamamoto A: Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5:494-6
16. Enhorning G: Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43:198-203
17. Rogers DF, Boschetto P, Barnes PJ: Plasma exudation: Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 1989; 21:309-15
18. Kageyama N, Miura M, Ichinose M, Tomaki M, Ishikawa J, Ohuchi Y, Endoh N, Shirato K: Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Eur Respir J 1997; 10:13-9
19. Gorin AB, Stewart PA: Differential permeability of endothelial and epithelial barriers to albumin flux. J Appl Physiol 1979; 47:1315-24
20. Effros RM, Mason GR, Silverman P, Reid E, Hukkanen J: Movements of ions and small solutes across endothelium and epithelium of perfused rabbit lungs. J Appl Physiol 1986; 60:100-7
21. Egan EA, Nelson RM, Olver RE: Lung overinflation and alveolar permeability to non-electrolytes in the adult sheep in vivo. J Appl Physiol 1976; 260:409-24
22. Egan EA: Response of alveolar epithelial solute permeability to changes in lung inflation. J Appl Physiol 1980; 49:1032-6
23. Albert RK, Lakshminarayan S, Hildebrandt J, Kirk W, Butler J: Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs. J Clin Invest 1979; 63:1015-8
24. Bredenberg CE, Nieman GF, Paskanik AM, Hart AKE: Microvascular membrane permeability in high surface tension pulmonary edema. J Appl Physiol 1986; 60:253-9
25. Dethloff LA, Gladen BC, Gilmore LB, Hook GER: Kinetics of pulmonary surfactant phosphatidylcholine metabolism in the lungs of silica-treated rats. Toxicol Appl Pharmacol 1989; 98:1-11
26. Taskar V, John J, Evander E, Robertson B, Jonson B: Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Resp Crit Care Med 1997; 155:313-20
27. 99mTc-DTPA and experimentally increased alveolar surfactant content. J Appl Physiol 1992; 72:1413-7
28. Seeger W, Stohr G, Wolf HRD, Neuhof H: Alternation of surfactant function due to protein leakage: Specific interaction with the fibrin monomer. J Appl Physiol 1985; 58:326-38
29. Lachmann B, Eijking EP, So KL, Gommers D: In vivo evaluation of the inhibitory capacity of human plasma of exogenous surfactant function. Intensive Care Med 1994; 20:6-11
30. Nilsson R, Grossmann G, Robertson B: Pathogenesis of neonatal lung lesions induced by artificial ventilation: Evidence against the role of barotrauma. Respiration 1980; 40:218-25
31. Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Resp Crit Care Med 1997; 155:1309-15